| JNJ 63533054 |
3-氯-N-[2-氧代-2-[[(1S)-1-苯基乙基]氨基]乙基]苯甲酰胺 |
1802326-66-4 |
| N-Hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide 2,2,2-Trifluoroacetate |
N-羟基-4-((2-甲基-3,4-二氢-1H-吡啶并[4,3-B]吲哚-5(2H)-基)甲基)苯甲酰胺 2,2,2-三氟乙酸盐 |
1239262-52-2 |
| BIA10-2474 |
3-(1-(环己基(甲基氨基甲酰基)-1H-咪唑-4-基)吡啶1-氧化物 |
1233855-46-3 |
| GSK-3326595 |
GSK-3326595 |
1616392-22-3 |
| XY1 |
N-2-萘基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 |
1624117-53-8 |
| WZB117 |
WZB-117 |
1223397-11-2 |
| Nexturastat A |
4-((1-BUTYL-3-PHENYLUREIDO)METHYL)-N-HYDROXYBENZAMIDE |
1403783-31-2 |
| Oclacitinib |
奥拉替尼 |
1208319-26-9 |
| BI-847325 |
BI-847325 |
1207293-36-4 |
| MK-5172 |
MK-5172 |
1206524-85-7 |
| DBCO-Acid |
11,12-二氢-Γ-氧代-二苯并[[F]偶氮-5-(6H)-丁酸 |
1353016-70-2 |
| MLN9708 |
艾沙佐米柠檬酸盐 |
1201902-80-8 |
| HSF1A |
HSF1 ACTIVATOR;HSF1A;CAS 1196723-93-9 |
1196723-93-9 |
| NXL 104 |
阿维巴坦钠 |
1192491-61-4 |
| BP-1-102 |
4-(N-(4-环己基苄基)-2-((2,3,4,5,6-五氟-N-甲苯基)磺酰氨基)乙酰氨基)-2-羟基苯甲酸 |
1334493-07-0 |
| 3-(Phenylmethyl)-2-[(1E)-2-(3-pyridinyl)ethenyl]-4(3H)-quinazolinone |
RAD51 INHIBITOR B02 |
1290541-46-6 |
| GS967 |
GS967 |
1262618-39-2 |
| NS-3-008（HCl） |
NS-3-008（HCl） |
1172854-54-4 |
| SKLB1002 |
SKLB1002 |
1225451-84-2 |
| (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid |
艾沙佐米 |
1072833-77-2 |
